Hepatitis B virus infection remains one of the leading causes of liver disease, including cirrhosis and hepatocellular carcinoma.

The US joins Moldova, Hong Kong, and New Zealand as countries to greenlight the company's Phase I trial of PBGENE-HBV.

Hepatitis E vaccine HEV 239 significantly reduces the risk of symptomatic hepatitis E among individuals with chronic ...

This day is marked to acknowledge and appreciate the hard work of frontline healthcare workers and to ensure the vaccination ...

Hepatitis B virus (HBV) infection remains an urgent global health concern, affecting hundreds of millions of people and significantly heightening the risk ...

Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...

The National Childhood Vaccine Injury Act of 1986 removed the economic incentive that held vaccine developers accountable for vaccine safety. Reforms, including properly designed trials, are needed to ...

The following is a summary of "Impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced ...

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

About the vaccine, how it works, how it is given, ingredients, allergies, possible side effects, safety monitoring ...

The newly published paper in The Lancet Global Health shows the importance of giving the hepatitis B birth dose vaccine (HepB-BD) within 24 hours of birth, and the potential impact of providing ...